Submitting OIG:
Report Description:
In 2016, OIG called attention to significant growth in spending for compounded drugs (customized medications tailored to meet the needs of individual patients). Specifically, OIG found that Medicare Part D spending for compounded drugs grew by 625 percent from 2006 to 2015 and spending for topical compounded drugs-such as creams, gels, and ointments to relieve pain-grew at an even faster pace.
Date Issued:
Tuesday, August 7, 2018
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
OEI-02-16-00440
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Inspection / Evaluation
Number of Recommendations:
4
View Document:
Attachment | Size |
---|---|
oei-02-16-00440.pdf | 1.2 MB |
Additional Details Link: